Skip to main content

Animal Models of Behçet’s Disease

  • Chapter
  • First Online:
Behçet’s Syndrome
  • 967 Accesses

Abstract

Animal models for Behçet’s disease (BD) can be divided according to the proposed etiological paradigms. These include environmental pollution and infectious (bacterial and viral) models, as well as various autoimmune and transgenic animal models. The environmental pollution model, though resembles the multisystem symptoms of BD, has limitations to become utilized as a model for the disease since it is difficult to produce and the onset of symptoms appears erratically in a wide time range. The Streptococcal models have similarity only to the eye involvement in BD. This model is simple to induce with high rate of homogeneity. The HSV model has multisystem manifestations resembling BD; it has a moderate reproducibility. The autoimmune model utilizing S-Ag is a monosymptomatic model of BD-like uveitis. This model is easy to induce, and extensive studies elucidated some of the immunological characteristics of BD including the paradigm of anti-HLA autoimmunity. The α-tropomyosin model shares some clinical features of BD. This model has a potential to become a useful autoimmune model for BD. The only published trial to establish a transgenic model for BD did not show any significant similarity to the human disease except hyper-responsiveness of neutrophils.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hori Y, Miyazawa S, Nishiyama S et al (1979) Experimental Behçet’s disease and ultrastructural X-ray microanalysis of pathological tissues. J Dermatol 6:31–37

    PubMed  CAS  Google Scholar 

  2. Bang D, Honma T, Saito T et al (1987) Electron microscopic observation on dark endothelial cells in erythema nodosum-like lesions of Behçet’s disease with ultrastructural X-ray spectroanalysis. J Toxicol Sci 12:321–328

    Article  PubMed  CAS  Google Scholar 

  3. Kaneko F, Oyama N, Nishibu A (1997) Streptococcal infection in the pathogenesis of Behçet’s disease and clinical effects of minocycline on the disease symptoms. Yonsei Med J 38:444–454

    PubMed  CAS  Google Scholar 

  4. Saenz A, Ausejo M, Shea B, et al. (2000) Pharmacotherapy for Behçet’s syndrome. Cochrane Database Syst Rev CD001084 Vol. 2

    Google Scholar 

  5. Sohn S, Lee ES, Bang D et al (1998) Behçet’s disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol 8:21–23

    PubMed  CAS  Google Scholar 

  6. Sohn S, Lee ES, Lee S (2001) The correlation of MHC haplotype and development of Behçet’s disease-like symptoms induced by herpes simplex virus in several inbred mouse strains. J Dermatol Sci 26:173–181

    Article  PubMed  CAS  Google Scholar 

  7. Bang D, Choi B, Kwon HJ et al (2008) Rebamipide affects the efficiency of colchicine for the herpes simplex virus-induced inflammation in a Behçet’s disease mouse model. Eur J Pharmacol 598:112–117

    Article  PubMed  CAS  Google Scholar 

  8. Choi B, Hwang Y, Kwon HJ et al (2008) Tumor necrosis factor alpha small interfering RNA decreases herpes simplex virus-induced inflammation in a mouse model. J Dermatol Sci 52:87–97

    Article  PubMed  CAS  Google Scholar 

  9. Javid B, MacAry PA, Lehner PJ (2007) Structure and function: heat shock proteins and adaptive immunity. J Immunol 179:2035–2040

    PubMed  CAS  Google Scholar 

  10. Hu W, Hasan A, Wilson A et al (1998) Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336–351. Eur J Immunol 28:2444–2455

    Article  PubMed  CAS  Google Scholar 

  11. de Smet MD, Bitar G, Mainigi S et al (2001) Human S-antigen determinant recognition in uveitis. Invest Ophthalmol Vis Sci 42:3233–3238

    PubMed  Google Scholar 

  12. Kurhan-Yavuz S, Direskeneli H, Bozkurt N et al (2000) Anti-MHC autoimmunity in Behçet’s disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis. Clin Exp Immunol 120:162–166

    Article  PubMed  CAS  Google Scholar 

  13. Mor F, Weinberger A, Cohen IR (2002) Identification of alpha-tropomyosin as a target self-antigen in Behçet’s syndrome. Eur J Immunol 32:356–365

    Article  PubMed  CAS  Google Scholar 

  14. Baharav E, Mor F, Halpern M et al (2004) Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J Nutr 134:1964–1969

    PubMed  CAS  Google Scholar 

  15. Ohno S, Ohguchi M, Hirose S et al (1982) Close association of HLA-Bw51 with Behçet’s disease. Arch Ophthalmol 100:1455–1458

    Article  PubMed  CAS  Google Scholar 

  16. Takeno M, Kariyone A, Yamashita N et al (1995) Excessive function of peripheral blood neutrophils from patients with Behçet’s disease and from HLA-B51 transgenic mice. Arthritis Rheum 38:426–433

    Article  PubMed  CAS  Google Scholar 

  17. Direskeneli H, (2001) Behçet’s disease infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60:996–1002

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ilan Krause .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Baharav, E., Weinberger, A., Mor, F., Krause, I. (2010). Animal Models of Behçet’s Disease. In: Yazıcı, Y., Yazıcı, H. (eds) Behçet’s Syndrome. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5641-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-5641-5_16

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-5640-8

  • Online ISBN: 978-1-4419-5641-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics